| Factor Information | |
|---|---|
| Data ID | 237 |
| Factor | pulmonary vascular resistance/systemic vascular resistance(PVR/SVR) |
| Description | N/A |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | CHD-PAH patients |
| p Value | 0.001 |
| Conclusion | MPAP, RVD, PVR, and PVR/SVR ratio were higher in Group I than in Group II and Control group |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 431 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | VSD/AVC/PDA/TGA/ASD/ASD, VSD |
| Reference | |
|---|---|
| PMID | 30618481 |
| Year | 2019 |
| Title | Predictive value of P-wave and QT interval dispersion in children with congenital heart disease and pulmonary arterial hypertension for the occurrence of arrhythmias. |
| Sample | ||
|---|---|---|
| Population | adolescents | |
| Source | data | |
| Region | Egypt, Tanta | |
| Method | hemodynamic echocardiographic measurement | |
| Race | African | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Group1-CHD with PAH(Treatment) | HC-healthy(Control) |
| Number | 40 | 40 |
| Age | 27.3±18.3 months | 27.5±17.6 months(HC) |
| Gender (Male: Female) | 26:14 | 22:18:00.000 |
| Marker Level | 0.4±0.1 | 0.10±0.03 |
